Correlation Between Monte Rosa and Janux Therapeutics
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Janux Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Janux Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Janux Therapeutics, you can compare the effects of market volatilities on Monte Rosa and Janux Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Janux Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Janux Therapeutics.
Diversification Opportunities for Monte Rosa and Janux Therapeutics
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Monte and Janux is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Janux Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janux Therapeutics and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Janux Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janux Therapeutics has no effect on the direction of Monte Rosa i.e., Monte Rosa and Janux Therapeutics go up and down completely randomly.
Pair Corralation between Monte Rosa and Janux Therapeutics
Given the investment horizon of 90 days Monte Rosa is expected to generate 1.92 times less return on investment than Janux Therapeutics. But when comparing it to its historical volatility, Monte Rosa Therapeutics is 1.63 times less risky than Janux Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Janux Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 1,323 in Janux Therapeutics on August 31, 2024 and sell it today you would earn a total of 3,198 from holding Janux Therapeutics or generate 241.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monte Rosa Therapeutics vs. Janux Therapeutics
Performance |
| Timeline |
| Monte Rosa Therapeutics |
| Janux Therapeutics |
Monte Rosa and Janux Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monte Rosa and Janux Therapeutics
The main advantage of trading using opposite Monte Rosa and Janux Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Janux Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janux Therapeutics will offset losses from the drop in Janux Therapeutics' long position.| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
| Janux Therapeutics vs. Mineralys Therapeutics, Common | Janux Therapeutics vs. Eliem Therapeutics | Janux Therapeutics vs. Anebulo Pharmaceuticals | Janux Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |